|Topic:||CDC Anthrax Vaccine Safety & Efficacy Research Program: Interim Report|
THE NATIONAL ACADEMIES
Institute of Medicine
Board of the Medical Follow-Up Agency
Committee to Review the Vaccine Safety and Efficacy Research Program
Friday, June 29, 2001 -- 1:00 p.m.
2407 Rayburn House Office Building
CDC Anthrax Vaccine Safety & Efficacy Research Program: Interim Report
The Centers for Disease Control and Prevention (CDC) contracted with the Institute of Medicine (IOM) to establish an expert panel to review the completeness and appropriateness of their research plan to study the safety and efficacy of the anthrax vaccine, and to evaluate alternative routes and schedules of administration in order to reduce adverse effects while maintaining vaccine effectiveness. The IOM study is planned for a total duration of 24 months.
This interim report sets out the IOM committee's findings, eight months into the project.
This briefing was for members of Congress and congressional staff only. The report was released on July 2, 2001 and can be found, in its entirety, on the Web site of the National Academies Press.